Jan 9 (Reuters) - The U.S. Environmental Protection Agency will reassess the safety of herbicide paraquat, its administrator Lee Zeldin said on Friday on X, adding that the body is requiring manufacturers to thoroughly prove that current uses are safe in real-world conditions.
Syngenta, which markets paraquat under the brand name Gramoxone, is among the herbicide's major sellers.
The Swiss-based agricultural chemical company is facing several lawsuits in the U.S., where plaintiffs allege exposure to paraquat caused them to develop Parkinson's, a degenerative brain disease that leads to loss of muscle coordination.
It has previously said there was "no credible evidence" that paraquat causes Parkinson's.
In agricultural settings, paraquat is mostly applied to soybean, corn and cotton crop fields to control invasive weeds and grasses, according to the Environmental Protection Agency.
(Reporting by Costas Pitas and Pooja Menon; Editing by Alan Barona)
latest_posts
- 1
Activists: Venezuela released just nine prisoners despite promise - 2Two policemen injured at religious youth protest in Jerusalem marking Ahuvia Sandak's death
- 3Five EU states press for windfall taxes on fossil energy sector
- 4Where America’s CO2 emissions come from – what you need to know, in charts
- 5Deadly heat worldwide prompts $300 million for climate health research at COP30
- Agricultural drones are taking off globally, saving farmers time and money
- How to watch the 2025 Macy's Thanksgiving Day Parade for free
- SF Chinatown's historic Empress of China building being revived into cultural campus
- U.S. to drop childhood vaccine recommendations as it looks to Denmark, Washington Post reports
- Pick Your Number one sort of blossom
- The most effective method to Execute a Lung-Solid Eating routine After a Cellular breakdown in the lungs Finding
- Make your choice for the music application with the most amicable connection point!
- US FDA unveils new pathway to approve personalized therapies
- MacArthur Foundation awards $100M to outbreak surveillance network, a boost amid global health cuts
